Argenx Soars on Latest Trial Success for Autoimmune Drug Vyvgart

bloomberg

·

Original Report

↗ bloomberg

Argenx SE’s shares jumped after the European biotech reported the latest large, successful trial for its blockbuster drug Vyvgart.